Total Neoadjuvant Therapy Versus Long-Course Chemoradiotherapy in Locally Advanced Rectal Cancer: Real-World Tumor Response and Clinical Outcomes
Medical Sciences · 14.07.2026 · 14 (3) · 393
DOI: 10.3390/medsci14030393 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Medical Sciences, online erschienen am 14.07.2026. Verfasst von Sorinel Lunca und 6 weiteren Autor:innen. Beteiligte Einrichtung: Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Chemoradiotherapy, Adenocarcinoma. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Total neoadjuvant therapy is becoming a preferred option for locally advanced rectal cancer, particularly in patients with high-risk baseline features. However, real-world evidence comparing tumor response, MRI-defined high-risk feature clearance, surgical outcomes, and survival after total neoadjuvant therapy versus conventional long-course chemoradiotherapy remains limited. This study aimed to compare outcomes between total neoadjuvant therapy and long-course chemoradiotherapy in patients with locally advanced rectal cancer treated in routine clinical practice.
Methods
This is a retrospective, single-centre cohort study focused on patients with stage II–III locally advanced rectal adenocarcinoma treated with curative-intent neoadjuvant therapy using either total neoadjuvant therapy or long-course chemoradiotherapy. Tumor response was assessed using restaging MRI, clinical complete response, and pathological complete response. Surgical outcomes and overall survival were evaluated.
Results
A total of 110 patients were included. Patients treated with total neoadjuvant therapy had a higher baseline disease burden reflected by a greater proportion of cT4 tumors (40.6% vs. 19.2%; p = 0.014). Radiologic tumor-length response and clearance of MRI-defined high-risk features were comparable between treatment strategies. Clinical and pathological complete response rates were numerically higher in the total neoadjuvant therapy group, but the differences were not significant (cCR: 15.6% vs. 6.4%, p = 0.151; pCR: 18.5% vs. 9.7%, p = 0.301).
Conclusions
In this real-world cohort, TNT was preferentially used in patients with more advanced baseline disease and showed numerically higher complete response rates, although differences were not statistically significant. Radiologic response, surgical outcomes, and short-term survival were comparable between treatment strategies. These findings support the feasibility of TNT in routine clinical practice but should be interpreted as exploratory and hypothesis-generating rather than evidence of treatment superiority.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
- 2nd Department of Surgical Oncology, Regional Institute of Oncology, 700483 Iasi, Romania.
ORCID-Profile: Sorinel Lunca, Stefan Morarasu
Zitieren
APA
Lunca, S., Ong, W. L., Morarasu, S., Musina, A. M., Roata, C. E., Zaharia, R., & Dimofte, G. M. (2026). Total Neoadjuvant Therapy Versus Long-Course Chemoradiotherapy in Locally Advanced Rectal Cancer: Real-World Tumor Response and Clinical Outcomes. Medical Sciences, 14(3), 393. https://doi.org/10.3390/medsci14030393
Vancouver
Lunca S, Ong WL, Morarasu S, Musina AM, Roata CE, Zaharia R, et al. Total Neoadjuvant Therapy Versus Long-Course Chemoradiotherapy in Locally Advanced Rectal Cancer: Real-World Tumor Response and Clinical Outcomes. Medical Sciences. 2026;14(3):393. doi:10.3390/medsci14030393
BibTeX
@article{Lunca2026,
author = {Lunca, Sorinel and Ong, Wee Liam and Morarasu, Stefan and Musina, Ana Maria and Roata, Cristian Ene and Zaharia, Raluca and Dimofte, Gabriel Mihail},
title = {Total Neoadjuvant Therapy Versus Long-Course Chemoradiotherapy in Locally Advanced Rectal Cancer: Real-World Tumor Response and Clinical Outcomes},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {3},
pages = {393},
doi = {10.3390/medsci14030393}
}
EUVIMED